Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke

NCT01123161 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT01123161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01123161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke
Lead sponsor
University of California, San Diego
Phase
Phase 2/3
Overall status
Terminated
Start date
June 30, 2010
Completion date
May 31, 2015
Enrollment
120 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute